AGAPE ATP CORPORATION Selling Expense
AGAPE ATP CORPORATION (ATPC) reported Selling Expense of $30.32 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2026-08-14
- AGAPE ATP CORPORATION selling expense for the quarter ending 2026-06-30 was $30.32K, a 49.36% decline year-over-year.
- AGAPE ATP CORPORATION selling expense for the quarter ending 2026-03-31 was $37.15K, a 41.08% decline year-over-year.
- AGAPE ATP CORPORATION selling expense for the quarter ending 2025-12-31 was $54.86K, a 67.39% increase year-over-year.
- AGAPE ATP CORPORATION selling expense for the quarter ending 2025-09-30 was $61.62K, a 48.20% increase year-over-year.
- AGAPE ATP CORPORATION selling expense for fiscal 2025 was $242.07K, a 48.77% increase from fiscal 2024.
- AGAPE ATP CORPORATION selling expense for fiscal 2024 was $162.71K, a 74.13% decline from fiscal 2023.
- AGAPE ATP CORPORATION selling expense for fiscal 2023 was $629.00K, a 74.04% increase from fiscal 2022.
- AGAPE ATP CORPORATION selling expense for fiscal 2022 was $361.41K, a 8.43% decline from fiscal 2021.
| Period end | Selling Expense 3 month | Selling Expense 3 month as first filed | Selling Expense 6 month | Selling Expense 6 month as first filed | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30.32K 10-Q · filed 2026-08-14 | $65.09K 10-Q · filed 2026-08-14 | $122.32K derived: sum of 3 quarters · filed 2026-08-14 | $183.95K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $37.15K 10-Q · filed 2026-05-15 | $92.01K derived: sum of 2 quarters · filed 2026-05-15 | $153.63K derived: sum of 3 quarters · filed 2026-05-15 | $213.50K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $54.86K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $116.48K derived: sum of 2 quarters · filed 2026-04-13 | $176.35K derived: sum of 3 quarters · filed 2026-08-14 | $242.07K 10-K · filed 2026-04-13 | ||
| 2025-09-30 | $61.62K 10-Q · filed 2025-11-13 | $121.49K derived: sum of 2 quarters · filed 2026-08-14 | $187.21K 10-Q · filed 2025-11-13 | $217.31K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $59.86K 10-Q · filed 2026-08-14 | $62.54K 10-Q · filed 2025-08-13 | $120.40K 10-Q · filed 2026-08-14 | $125.59K 10-Q · filed 2025-08-13 | $155.69K derived: sum of 3 quarters · filed 2026-08-14 | $197.27K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $63.05K 10-Q · filed 2026-05-15 | $95.83K derived: sum of 2 quarters · filed 2026-05-15 | $137.41K derived: sum of 3 quarters · filed 2026-05-15 | $175.42K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $32.77K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $74.36K derived: sum of 2 quarters · filed 2026-04-13 | $112.36K derived: sum of 3 quarters · filed 2026-04-13 | $162.71K 10-K · filed 2026-04-13 | ||
| 2024-09-30 | $41.58K 10-Q · filed 2025-11-13 | $79.59K derived: sum of 2 quarters · filed 2025-11-13 | $129.94K 10-Q · filed 2025-11-13 | $569.43K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $38.01K 10-Q · filed 2025-08-13 | $88.36K 10-Q · filed 2025-08-13 | $527.85K derived: sum of 3 quarters · filed 2025-08-13 | $577.13K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $50.35K 10-Q · filed 2025-05-15 | $489.84K derived: sum of 2 quarters · filed 2025-05-15 | $539.13K derived: sum of 3 quarters · filed 2025-05-15 | $603.25K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $439.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $488.78K derived: sum of 2 quarters · filed 2025-03-31 | $552.90K derived: sum of 3 quarters · filed 2025-03-31 | $629.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $49.28K 10-Q · filed 2024-11-14 | $113.41K derived: sum of 2 quarters · filed 2024-11-14 | $189.51K 10-Q · filed 2024-11-14 | $280.69K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $64.13K 10-Q · filed 2024-08-14 | $140.22K 10-Q · filed 2024-08-14 | $231.41K derived: sum of 3 quarters · filed 2024-08-14 | $307.44K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $76.10K 10-Q · filed 2024-05-14 | $167.28K derived: sum of 2 quarters · filed 2024-05-14 | $243.31K derived: sum of 3 quarters · filed 2024-05-14 | $322.90K derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $91.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $167.22K derived: sum of 2 quarters · filed 2024-04-01 | $246.80K derived: sum of 3 quarters · filed 2024-04-01 | $361.41K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $76.03K 10-Q · filed 2023-11-14 | $155.62K derived: sum of 2 quarters · filed 2023-11-14 | $270.23K 10-Q · filed 2023-11-14 | $365.10K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $79.59K 10-Q · filed 2023-08-14 | $194.20K 10-Q · filed 2023-08-14 | $289.07K derived: sum of 3 quarters · filed 2023-08-14 | $371.93K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $114.61K 10-Q · filed 2023-05-15 | $209.49K derived: sum of 2 quarters · filed 2023-05-15 | $292.34K derived: sum of 3 quarters · filed 2023-05-15 | $393.18K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $94.88K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $177.73K derived: sum of 2 quarters · filed 2023-03-31 | $278.57K derived: sum of 3 quarters · filed 2023-03-31 | $394.68K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $82.85K 10-Q · filed 2022-11-14 | $183.69K derived: sum of 2 quarters · filed 2022-11-14 | $299.81K 10-Q · filed 2022-11-14 | $407.74K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $100.84K 10-Q · filed 2022-08-11 | $216.95K 10-Q · filed 2022-08-11 | $324.89K derived: sum of 3 quarters · filed 2022-08-11 | $484.18K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $116.11K 10-Q · filed 2022-05-13 | $224.05K derived: sum of 2 quarters · filed 2022-07-05 | $383.34K derived: sum of 3 quarters · filed 2022-07-05 | $492.23K derived: sum of 4 quarters · filed 2022-07-05 | ||
| 2020-12-31 | $107.93K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | $267.23K derived: sum of 2 quarters · filed 2022-07-05 | $376.12K derived: sum of 3 quarters · filed 2022-07-05 | $376.58K 10-K/A · filed 2022-07-05 | ||
| 2020-09-30 | $159.29K 10-Q/A · filed 2022-07-05 | $268.19K derived: sum of 2 quarters · filed 2022-07-05 | $268.65K 10-Q/A · filed 2022-07-05 | |||
| 2020-06-30 | $108.89K 10-Q · filed 2021-08-13 | $109.36K 10-Q · filed 2021-08-13 | ||||
| 2019-12-31 | -$338.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $6.50K derived: sum of 3 quarters · filed 2021-03-31 | $7.85K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $338.00 10-Q · filed 2020-11-16 | $6.84K derived: sum of 2 quarters · filed 2020-11-16 | $8.18K 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | $6.50K 10-Q · filed 2020-08-13 | $7.85K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |